my timesThe Korea Times
baekby

Baek Byung-yeul

Korea Times K-Culture Reporter

Baek Byung-yeul is a journalist at The Korea Times focused on cultural content, including films and cultural events in South Korea. You can contact him at baekby@koreatimes.co.kr to share your insights.

Go to Email

Read more

Companies

BIO WEBINAR SK Bioscience comes up with 2-track strategy to become global vaccine powerhouse

Lee Sang-mok, head of Strategic Planning Division of SK Bioscience, speaks during The Korea Times' Bio Webinar, March 26. Captured during the eventBy Baek Byung-yeulLogo for SK BioscienceSK Bioscience has set its sights on becoming the global vaccine powerhouse by developing its own COVID-19 vaccine and expanding its contract development and manufacturing organization (CDMO) business, said Lee Sang-mok, head of the company's Strategic Planning Division, March 26.“SK Bioscience is implementing a two-track strategy ― developing our own vaccines and manufacturing and distributing vaccines developed by global vaccine makers. Based on our capabilities in every process in vaccine business, we are aiming to become a vaccine specialist company,” Lee said during The Korea Times' Bio Webinar. The Korea Times hosted the online seminar to shed light on the government's steps to attract global biotech entities for its plan to build a cluster here, and discuss diverse issues regarding the biotech industry.Park Jae-young, director general of the Manufacturing Industry Department at the

Mar 28, 2021By Baek Byung-yeul
[BIO WEBINAR] SK Bioscience comes up with 2-track strategy to become global vaccine powerhouse
  • BIO WEBINAR 'Samsung Biologics aims to offer speedy, timely drug development service'
  • BIO WEBINAR Korean gov't vows full support for bolstering bio industry
Companies

BIO WEBINAR 'Celltrion will complete Phase 3 trial of COVID treatment within H1 2021'

Lee Soo-young, vice president at Celltrion, speaks during The Korea Times' Bio Webinar, March 26. Captured during the eventBy Baek Byung-yeulLogo for CelltrionCelltrion aims to complete the Phase 3 clinical trial of its Regkirona anti-COVID-19 drug, also known as CT-P59, within the first half of 2021, Lee Soo-young, vice president of Celltrion, said during The Korea Times' Bio Webinar, March 26.“We are currently conducting Phase 3 clinical trials of the Regkirona against 1,172 patients with mid-to-moderate symptoms of COVID-19 in some 10 countries including the United States, Spain, South Africa and Hungary,” he said. “We are aiming to complete the Phase 3 clinical trials of the Regkirona within the first half of this year and will go through formal approval procedures.”The inaugural event featured executives from four major biotech companies here including Celltrion, Samsung Biologics, LG Chem and SK Bioscience as well as the director general from the Ministry of Trade, Industry and Energy. They discussed what needs to be improved to enhance the country's com

Mar 28, 2021By Baek Byung-yeul
[BIO WEBINAR] 'Celltrion will complete Phase 3 trial of COVID treatment within H1 2021'
  • BIO WEBINAR 'Samsung Biologics aims to offer speedy, timely drug development service'
  • BIO WEBINAR Korean gov't vows full support for bolstering bio industry
Companies

BIO WEBINAR 'Samsung Biologics aims to offer speedy, timely drug development service'

Ahn Yong-ho, vice president and head of CDO business unit at Samsung Biologics, speaks during The Korea Times' Bio Webinar, March 26. Captured during the eventBy Baek Byung-yeulLogo for Samsung BiologicsThe outbreak of COVID-19 has provided Korea with the momentum to look back on how well the country has nurtured its biotechnology industry. Some firms have responded swiftly to the market's need for reliable test kits to diagnose the novel virus and other companies have gone all-out to manufacture vaccines and treatments. Taking the pandemic as a turning point, the country's biotechnology firms are readying to take the giant leap forward to compete against global players.Specializing in the development and manufacturing of biopharmaceutical products for global pharmaceutical firms, Samsung Biologics is one of the local companies leading the country as a rising player in the biotechnology industry. The company has also been working on expanding its business scope to develop its contract development organization (CDO) business, an end-to-end biopharmaceutical project running drug develo

Mar 28, 2021By Baek Byung-yeul
[BIO WEBINAR] 'Samsung Biologics aims to offer speedy, timely drug development service'
  • BIO WEBINAR LG Chem speeding up new drug development
  • BIO WEBINAR 'Celltrion will complete Phase 3 trial of COVID treatment within H1 2021'
  • BIO WEBINAR SK Bioscience comes up with 2-track strategy to become global vaccine powerhouse
  • BIO WEBINAR Korean gov't vows full support for bolstering bio industry
Tech & Science

Samsung on high alert over Intel's foundry investments

From left, TSMC Chairman Mark Liu, Samsung Electronics Vice Chairman Lee Jae-yong and Intel CEO Pat Gelsinger / Courtesy of the companiesBy Baek Byung-yeulSemiconductor behemoth Intel announced a $20 billion investment plan on Wednesday (KST) to build two new chip-manufacturing factories in the U.S. state of Arizona and open up its plants to outside customers.Sharing the company's new vision called IDM 2.0, a new version of its integrated device manufacturing (IDM) model, Intel CEO Pat Gelsinger said the company will use the strategy to “design the best products and manufacture them in the best way possible for every category we compete in.” To catch up to the leaders in the foundry business, Intel also revealed its plan to develop thinner 7-nanometer chips, using extreme ultra violet (EUV) processing technology.The move apparently aims to reduce the U.S.'s heavy reliance on chip making firms in Asian countries. It is also in line with the Joe Biden administration's pledge to boost the local chip supply chain as semiconductors have been increasingly regarded as a strategi

Mar 24, 2021By Baek Byung-yeul
Samsung on high alert over Intel's foundry investments
Tech & Science

Industries grappling with deepening chip shortage

By Baek Byung-yeulThe global economy is now likely to bounce back to the pre-pandemic level as more and more people are vaccinated, but various industry sectors, including electronics and cars, are grappling with semiconductor shortages and supply chain deterioration.The shortages come as chip makers have given priority to chips for IT devices and home appliances, which have been in robust demand during the COVID-19 pandemic. The chip supply chain began to show its vulnerability as chip makers have been hit hard by heavy weather and natural disasters.Samsung Electronics, NXP and Infineon had to shut down their contract-based chip-making factories in Texas in February due to power outages after an unprecedented winter storm. Samsung is the world's largest memory chip maker and the second-largest foundry company while NXP and Infineon are leading automotive chipmakers.An earthquake in Japan last month has worsened the chip shortages. No. 3 automotive chip maker Renesas Electronics also shut down its factory for two days in February after the 7.3-maginitude earthquake hit the country. A

Mar 23, 2021By Baek Byung-yeul
Industries grappling with deepening chip shortage
Companies

S-OIL bolsters ESG management

S-OIL's residue hydro-desulfurization facility in Ulsan / Courtesy of S-OILBy Baek Byung-yeulS-OIL is ramping up environmental, social and corporate governance (ESG) management by starting the operation of eco-friendly facilities to cut emissions, the refiner said Tuesday.The company said it began operation of a residue hydro-desulfurization (RHDS) on March 20. Earlier the same month, the refiner began to run a vapor combustion unit (VCU). S-Oil invested 73 billion won into the expansion of the RHDS capacity and the construction of the VCU.“The RHDS is an eco-friendly facility that curbs emissions during the process of producing fuels by removing impurities from high-sulfur residue oil used as feedstock through catalytic hydrogenation processes in high-temperature, high-pressure reactors,” the company said.Thanks to the new facility, the residue oil quantity desulfurized by the newly build RHDS has increased by 18 percent to 40,000 barrels a day, from 34,000 barrels a day. Desulfurized residue oil turns into light fuels such as ultra-low sulfur diesel and naphtha by under

Mar 23, 2021By Baek Byung-yeul
S-OIL bolsters ESG management
Companies

Hyundai unveils EV recharging station brand, E-pit

Seen is an illustration of Hyundai Motor Group's electric vehicle (EV) charging station, provided by the group, Tuesday. The automotive group said it will run its EV charging station business under the brand E-pit. Courtesy of Hyundai Motor GroupBy Baek Byung-yeulHyundai Motor Group is jumping into the electric vehicle (EV) charging station business here, unveiling its new brand E-pit, Tuesday.The group said it will set up 20 E-pit EV charging stations with ultra-fast chargers across the country this year. Inspired by the pit stops of the Formula One racing event, which involve brief pauses for refueling, repairs and changing tires, its E-pit is designed to offer fast, easy, convenient and premium services to customers.“At E-pit stations, owners of Hyundai Motor Group's EVs with 800-volt charging capabilities can charge their vehicles to 80 percent within 18 minutes. By charging their vehicles for only five minutes they also can drive about 100 kilometers,” the company said.Hyundai said 12 E-pit stations with a total of 72 EV chargers will be established at 12 highway res

Mar 23, 2021By Baek Byung-yeul
Hyundai unveils EV recharging station brand, E-pit
Tech & Science

SK hynix CEO shares future vision of memory chips

SK hynix CEO Lee Seok-hee speaks during the Institute of Electrical and Electronics Engineers International Reliability Physics Symposium (IEEE IRPS), held online, Monday. Courtesy of SK hynixBy Baek Byung-yeulSK hynix CEO Lee Seok-heeLee Seok-hee, CEO of memory chip maker SK hynix, stressed that demand for memory chips will be on the rise as social-distancing has become the new normal, while their role will also expand in the future beyond existing functions such as storing and processing data.“In the era of fierce competition for miniaturization, the matters of technology completion and productivity were dealt with through vertical relations with suppliers,” the CEO said in a keynote speech to the Institute of Electrical and Electronics Engineers (IEEE) International Reliability Physics Symposium (IRPS), Monday.The IEEE IRPS has been a conference for engineers and scientists in the microelectronics field for 59 years and this year's event was held online.The CEO also emphasized that SK hynix will work to improve quality of life in the modern world through advanced techn

Mar 22, 2021By Baek Byung-yeul
SK hynix CEO shares future vision of memory chips
Tech & Science

Samsung Galaxy M phones to use Chinese OLEDs

Samsung Electronics' Galaxy M smartphone / Captured from Samsung Electronics India webpageBy Baek Byung-yeulSamsung Electronics has signed a contract with BOE to use smartphone displays made by the Chinese manufacturer as part of its effort to reduce production cost and consequently retain its leading position as the world's top smartphone maker, according to industry sources, Monday.Under the contract, the sources said, Samsung is scheduled to adopt OLED panels from Chinese display maker BOE for its new budget Galaxy M smartphones, which will be released in the second half of this year.This is the first time for BOE to supply its flexible OLED panels to Samsung, though the Chinese maker previously supplied its LCDs. OLEDs are considered more advanced compared to LCDs as they are much brighter and have a faster response time.The deal took place as BOE has been desperate to find new customers while Huawei, one of the biggest clients of the display maker, has decreased smartphone production after being hit by the U.S. government's sanctions banning the company's supply of components ma

Mar 22, 2021By Baek Byung-yeul
Samsung Galaxy M phones to use Chinese OLEDs
Companies

Hyundai's Genesis GV80 SUV chosen as top safety pick in US

Genesis GV80 SUV / Courtesy of Hyundai Motor GroupBy Baek Byung-yeulThe GV80, an SUV model of Hyundai Motor Group's Genesis luxury brand, has been recognized as one of the safest vehicles in the United States in crash test ratings by the Insurance Institute for Highway Safety (IIHS), the automotive group said Friday.IIHS, an organization funded by auto insurance companies, said Genesis' luxury SUV GV80 earned a TOP SAFETY PICK+ award after receiving good ratings in its crashworthiness tests.According to IIHS, the SUV underwent six tests: driver- and passenger-side small overlap front, moderate overlap front, side, roof strength and head restraints.To earn the TOP SAFETY PICK+ rating, a vehicle must pass front crash prevention tests and earn a superior or advanced rating in both vehicle-to-vehicle and vehicle-to-pedestrian evaluations. Also, the car needs to have good or acceptable headlights across all trim levels and packages.“With a standard front crash prevention system that earned superior ratings in both evaluations, as well as standard acceptable-rated LED projector headl

Mar 20, 2021By Baek Byung-yeul
Hyundai's Genesis GV80 SUV chosen as top safety pick in US
previous page
215216217218219
next page

Top 5 stories

Korea Times
About Us
Introduction
History
Contact Us
Products & Services
Subscribe
E-paper
RSS Service
Content Sales
Site Map
Policy
Code of Ethics
Ombudsman
Privacy Policy
Youth Protection Policy
Terms of Service
Copyright Policy
Family Site
Hankookilbo
Dongwha Group
FacebookXYoutubeInstagram
CEO & Publisher: Oh Young-jinDigital News Email: webmaster@koreatimes.co.krTel: 02-724-2114Online newspaper registration No: 서울,아52844Date of registration: 2020.02.05Masthead: The Korea TimesCopyright © koreatimes.co.kr. All rights reserved.